Q2 2026 Medifast Inc Earnings Call Transcript
Key Points
- Revenue has stabilized sequentially over recent quarters, with coach productivity growing for the third consecutive quarter.
- Active earning coach productivity increased 41% year-over-year and 20% sequentially, reaching the highest level since Q2 2022.
- The launch of the new Trilivy brand and MetaVantage technology platform strengthens market differentiation in the metabolic health category.
- The company maintains a strong balance sheet with over $169 million in cash and investments and no debt.
- The new enhanced compensation plan and coach training platform are designed to improve field performance and drive sustainable growth.
- Revenue decreased 27.6% year-over-year to $76.4 million, driven by a 48.7% decline in active earning coaches.
- The company continues to face headwinds from the rapid adoption of GLP-1 medications, impacting the traditional weight loss category.
- Gross profit margin declined to 69.9% from 72.6% due to loss of leverage on fixed costs.
- Net loss of $3.1 million in Q2 2026, compared to net income of $2.5 million in the prior year period.
- The company expects active earning coach count to continue declining in the short-term, with Q3 revenue guidance of $60-80 million indicating potential further weakness.
Greetings and welcome to the Medifast second quarter 2026 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Steven Zenker, Vice President, Investor Relations. Thank you, sir. You may begin.
Good afternoon, and welcome to Medifast's second quarter 2026 earnings conference call. On the call with me today are Nick Johnson, Chief Executive Officer;and Jim Maloney, Chief Financial Officer.
By now, everyone should have access to the earnings release for the second quarter ended June 30, 2026, that went out this afternoon at approximately 4.05 PM Eastern Time. If you have not received the release, it is available on the Investor Relations portion of Medifast's website at www.medifastinc.com. This call is being webcast and a replay will also be available on the company's website.
Before we begin, we would like to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
